669 related articles for article (PubMed ID: 24130075)
1. Long-acting reversible contraception: a review in special populations.
Prescott GM; Matthews CM
Pharmacotherapy; 2014 Jan; 34(1):46-59. PubMed ID: 24130075
[TBL] [Abstract][Full Text] [Related]
2. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
3. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
5. Long acting reversible contraception in adolescents with cardiovascular conditions.
Amies Oelschlager AM; Micks EA; Debiec KE; Nizamic T; Mantrala MD; Prager SW
J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):353-5. PubMed ID: 25256877
[TBL] [Abstract][Full Text] [Related]
6. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
Meirik O; Brache V; Orawan K; Habib NA; Schmidt J; Ortayli N; Culwell K; Jackson E; Ali M;
Contraception; 2013 Jan; 87(1):113-20. PubMed ID: 23063337
[TBL] [Abstract][Full Text] [Related]
7. The safety of intrauterine devices among young women: a systematic review.
Jatlaoui TC; Riley HEM; Curtis KM
Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475
[TBL] [Abstract][Full Text] [Related]
8. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
9. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.
Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553
[TBL] [Abstract][Full Text] [Related]
10. Contraceptive procedures.
Beasley A; Schutt-Ainé A
Obstet Gynecol Clin North Am; 2013 Dec; 40(4):697-729. PubMed ID: 24286997
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
Mavranezouli I;
Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257
[TBL] [Abstract][Full Text] [Related]
12. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
[TBL] [Abstract][Full Text] [Related]
13. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
Eggebroten JL; Sanders JN; Turok DK
Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
[TBL] [Abstract][Full Text] [Related]
14. Long-acting reversible contraceptive (LARCs) methods.
Bahamondes L; Fernandes A; Monteiro I; Bahamondes MV
Best Pract Res Clin Obstet Gynaecol; 2020 Jul; 66():28-40. PubMed ID: 32014434
[TBL] [Abstract][Full Text] [Related]
15. Contraceptive implants.
McDonald-Mosley R; Burke AE
Semin Reprod Med; 2010 Mar; 28(2):110-7. PubMed ID: 20352560
[TBL] [Abstract][Full Text] [Related]
16. Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.
Rose SB; Garrett SM; Stanley J
Contraception; 2015 Jul; 92(1):17-25. PubMed ID: 25818594
[TBL] [Abstract][Full Text] [Related]
17. Long-acting reversible contraception.
Peck SA
Nurs Womens Health; 2013 Oct; 17(5):431-5. PubMed ID: 24138662
[TBL] [Abstract][Full Text] [Related]
18. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
[TBL] [Abstract][Full Text] [Related]
19. Reversible contraception for the woman over 35 years of age.
Archer DF
Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
[TBL] [Abstract][Full Text] [Related]
20. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
Tocce K; Sheeder J; Python J; Teal SB
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
